Brent Egan to Comorbidity
This is a "connection" page, showing publications Brent Egan has written about Comorbidity.
Connection Strength
0.514
-
Systolic Blood Pressure Intervention Trial (SPRINT) and Target Systolic Blood Pressure in Future Hypertension Guidelines. Hypertension. 2016 08; 68(2):318-23.
Score: 0.101
-
Blood pressure and cholesterol control in hypertensive hypercholesterolemic patients: national health and nutrition examination surveys 1988-2010. Circulation. 2013 Jul 02; 128(1):29-41.
Score: 0.082
-
Impact of the number of blood pressure measurements on blood pressure classification in US adults: NHANES 1999-2008. J Clin Hypertens (Greenwich). 2012 Nov; 14(11):751-9.
Score: 0.078
-
Demographic differences in the treatment and control of glucose in type 2 diabetic patients: implications for health care practice. Ethn Dis. 2012; 22(1):29-37.
Score: 0.074
-
Uncontrolled and apparent treatment resistant hypertension in the United States, 1988 to 2008. Circulation. 2011 Aug 30; 124(9):1046-58.
Score: 0.072
-
Prehypertension: an opportunity for a new public health paradigm. Cardiol Clin. 2010 Nov; 28(4):561-9.
Score: 0.068
-
Chaos to complexity: leveling the playing field for measuring value in primary care. J Eval Clin Pract. 2017 Apr; 23(2):430-438.
Score: 0.023
-
Office and ambulatory blood pressure-lowering effects of combination valsartan/hydrochlorothiazide vs. hydrochlorothiazide-based therapy in obese, hypertensive patients. J Clin Hypertens (Greenwich). 2011 Oct; 13(10):731-8.
Score: 0.018